159 related articles for article (PubMed ID: 30429017)
21. Leucine-rich repeats and immunoglobulin-like domains protein 1 and fascin actin-bundling protein 1 expression in nonsmall cell lung cancer.
Zhang J; Wang X; Zhang Y; Wu J; Zhou N
J Cancer Res Ther; 2016 Dec; 12(Supplement):C248-C251. PubMed ID: 28230028
[TBL] [Abstract][Full Text] [Related]
22. The Prognostic Role of LRIG Proteins in Endometrial Cancer.
Razumova Z; Oda H; Govorov I; Lundin E; Östensson E; Lindquist D; Mints M
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33802837
[TBL] [Abstract][Full Text] [Related]
23. Vertebrate Lrig3-ErbB interactions occur in vitro but are unlikely to play a role in Lrig3-dependent inner ear morphogenesis.
Abraira VE; Satoh T; Fekete DM; Goodrich LV
PLoS One; 2010 Feb; 5(2):e8981. PubMed ID: 20126551
[TBL] [Abstract][Full Text] [Related]
24. Ligand-specific regulation of transforming growth factor beta superfamily factors by leucine-rich repeats and immunoglobulin-like domains proteins.
Abdullah A; Herdenberg C; Hedman H
PLoS One; 2023; 18(8):e0289726. PubMed ID: 37603563
[TBL] [Abstract][Full Text] [Related]
25. Soluble LRIG2 ectodomain is released from glioblastoma cells and promotes the proliferation and inhibits the apoptosis of glioblastoma cells in vitro and in vivo in a similar manner to the full-length LRIG2.
Xiao Q; Tan Y; Guo Y; Yang H; Mao F; Xie R; Wang B; Lei T; Guo D
PLoS One; 2014; 9(10):e111419. PubMed ID: 25353163
[TBL] [Abstract][Full Text] [Related]
26. The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea.
Guo D; Holmlund C; Henriksson R; Hedman H
Genomics; 2004 Jul; 84(1):157-65. PubMed ID: 15203213
[TBL] [Abstract][Full Text] [Related]
27. Expression of LRIG1 is Associated With Good Prognosis for Human Non-small Cell Lung Cancer.
An Y; Zhao Z; Ou P; Wang G
Medicine (Baltimore); 2015 Nov; 94(47):e2081. PubMed ID: 26632716
[TBL] [Abstract][Full Text] [Related]
28. Expression of leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins in human ependymoma relates to tumor location, WHO grade, and patient age.
Yi W; Haapasalo H; Holmlund C; Järvelä S; Raheem O; Bergenheim AT; Hedman H; Henriksson R
Clin Neuropathol; 2009; 28(1):21-7. PubMed ID: 19216216
[TBL] [Abstract][Full Text] [Related]
29. Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity.
Wu X; Hedman H; Bergqvist M; Bergström S; Henriksson R; Gullbo J; Lennartsson J; Hesselius P; Ekman S
Acta Oncol; 2012 Jan; 51(1):69-76. PubMed ID: 21417672
[TBL] [Abstract][Full Text] [Related]
30. Characterization and tissue-specific expression of human LRIG2.
Holmlund C; Nilsson J; Guo D; Starefeldt A; Golovleva I; Henriksson R; Hedman H
Gene; 2004 May; 332():35-43. PubMed ID: 15145052
[TBL] [Abstract][Full Text] [Related]
31. Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival.
Holmlund C; Haapasalo H; Yi W; Raheem O; Brännström T; Bragge H; Henriksson R; Hedman H
Neuropathology; 2009 Jun; 29(3):242-7. PubMed ID: 18992012
[TBL] [Abstract][Full Text] [Related]
32. LRIG proteins regulate lipid metabolism via BMP signaling and affect the risk of type 2 diabetes.
Herdenberg C; Mutie PM; Billing O; Abdullah A; Strawbridge RJ; Dahlman I; Tuck S; Holmlund C; Arner P; Henriksson R; Franks PW; Hedman H
Commun Biol; 2021 Jan; 4(1):90. PubMed ID: 33469151
[TBL] [Abstract][Full Text] [Related]
33. Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer.
Lindquist D; Näsman A; Tarján M; Henriksson R; Tot T; Dalianis T; Hedman H
Br J Cancer; 2014 Apr; 110(7):1793-800. PubMed ID: 24548859
[TBL] [Abstract][Full Text] [Related]
34. Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR.
Torigoe H; Yamamoto H; Sakaguchi M; Youyi C; Namba K; Sato H; Shien K; Soh J; Suzawa K; Tomida S; Tsukuda K; Miyoshi S; Toyooka S
Carcinogenesis; 2018 May; 39(5):719-727. PubMed ID: 29546323
[TBL] [Abstract][Full Text] [Related]
35. TTF-1/Nkx2.1 functional connection with mutated EGFR relies on LRIG1 and β-catenin pathways in lung cancer cells.
Zamboni M; Civitareale D
Biochem Biophys Res Commun; 2018 Nov; 505(4):1027-1031. PubMed ID: 30314701
[TBL] [Abstract][Full Text] [Related]
36. LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer.
Lindquist D; Alsina FC; Herdenberg C; Larsson C; Höppener J; Wang N; Paratcha G; Tarján M; Tot T; Henriksson R; Hedman H
Int J Oncol; 2018 Apr; 52(4):1189-1197. PubMed ID: 29436694
[TBL] [Abstract][Full Text] [Related]
37. Expression of LRIG1, a Negative Regulator of EGFR, Is Dynamically Altered during Different Stages of Gastric Carcinogenesis.
Yu S; Yang M; Lim KM; Cho Y; Kim H; Lee K; Jeong SH; Coffey RJ; Goldenring JR; Nam KT
Am J Pathol; 2018 Dec; 188(12):2912-2923. PubMed ID: 30248341
[TBL] [Abstract][Full Text] [Related]
38. Redistribution of LRIG proteins in psoriasis.
Karlsson T; Mark EB; Henriksson R; Hedman H
J Invest Dermatol; 2008 May; 128(5):1192-5. PubMed ID: 18037903
[TBL] [Abstract][Full Text] [Related]
39. [Gene therapy study on bladder cancer with recombinant adenoviral vector carrying LRIG1 gene driven by Survivin promoter].
Yan ZJ; Cheng Y; Jiang JH; Hu JS; Shi XD
Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):732-6. PubMed ID: 23157908
[TBL] [Abstract][Full Text] [Related]
40. LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor.
Ji Y; Kumar R; Gokhale A; Chao HP; Rycaj K; Chen X; Li Q; Tang DG
Semin Cancer Biol; 2022 Jul; 82():120-133. PubMed ID: 33476721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
